HIP1 as a marker of aggressive prostate cancer

Chan, E Y W (2002) HIP1 as a marker of aggressive prostate cancer. Clinical Genetics, 62 (5). pp. 372-375. ISSN 0009-9163 (https://doi.org/10.1034/j.1399-0004.2002.620503_4....)

Abstract

A recent report from Theadora Ross’s group describes an exciting link between huntingtin interacting protein-1 (HIP1) and prostate cancer, providing further evidence for a critical role of this protein in the regulation of cell survival. HIP1 was initially identified by virtue of its interaction with huntingtin, the protein mutated in the neurodegenerative disorder Huntington disease (HD). The role of HIP1 in HD has been postulated to reflect a pro-apoptotic function in the cytoplasm (4,5).

• Share and Export
  

  ReferAtomJSONOpenURL ContextObject in SpanMPEG-21 DIDLRDF+XMLRDF+N-TriplesRefWorksHTML CitationEndNoteMultiline CSVRIS (EndNote Online, Zotero, Ref manager, etc)Data Cite XMLDublin CoreEP3 XMLASCII CitationRDF+N3METSSimple MetadataRIOXX2 XMLBibTeXOpenURL ContextObjectMODS
• Item metadata

  Item type:	Article
  ID code:	49625
  Dates:	Date Event November 2002 Published
  Subjects:	Medicine > Pharmacy and materia medica
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
  Depositing user:	Pure Administrator
  Date deposited:	06 Oct 2014 14:04
  Last modified:	11 Nov 2024 10:48
  URI:	https://strathprints.strath.ac.uk/id/eprint/49625